3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Corynebacterium Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blobner, M; Jeevendra Martyn, JA; Kem, WR; Khan, MAS; Lewald, H; Nagashima, M; Sasakawa, T; Schaller, SJ; Schlegel, J; Schneider, G; Schönfelder, M; Schulz, F | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Corynebacterium Infections
Article | Year |
---|---|
GTS-21 attenuates loss of body mass, muscle mass, and function in rats having systemic inflammation with and without disuse atrophy.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Body Weight; Corynebacterium Infections; Immobilization; Male; Methemoglobin; Muscle, Skeletal; Muscular Atrophy; Nicotinic Agonists; Pyridines; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome | 2018 |